Vantiq, a global leader in developing and managing real-time intelligent systems, announced a strategic partnership with TransformativeMed, the company behind the highly regarded CORES Platform. This collaboration establishes TransformativeMed as the go-to agentic-AI platform for Oracle Health clients who want to strengthen their Millennium EHR with fully integrated clinical and […]
admin
Olympus and MacroLux Partner to Expand Global Access to Single-Use Urology Devices
Olympus Corporation, a global leader in medical technology committed to improving health, safety, and quality of life, has announced an exclusive global distribution agreement with MacroLux Medical Technology Co. This new collaboration will allow Olympus to distribute MacroLux Medical’s single-use urology products across the United States, Canada, various European countries, […]
A collaboration between BrainSpec and the University of Minnesota aims to advance automated MR spectroscopy through the use of AutoVOI
The Center for Magnetic Resonance Research (CMRR) at the University of Minnesota has teamed up with BrainSpec, a business that develops next-generation imaging technology, to introduce AutoVOI, a proprietary pipeline for automated voxel placement in MR spectroscopy, to the general public. Through an exclusive licensing agreement managed by the University’s […]
To streamline the healthcare data science workflow, Nimblemind launches NimbleLabs
Nimblemind, an AI company dedicated to helping healthcare providers and researchers maximize the value of their data, has announced the launch of NimbleLabs. This new platform is a lightweight, AI-powered solution designed to make clinical data enrichment accessible to data scientists, researchers, and students alike. With its simple upload-and-enrich workflow, […]
Golden Helix and Genomenon Partner to Deliver Integrated, Literature-Backed Genomic Insights
Golden Helix, a global pioneer in clinical bioinformatics, has announced a strategic collaboration with Genomenon to integrate its Mastermind Genomic Intelligence Platform and Cancer Knowledgebase (CKB) into the Golden Helix software ecosystem. This partnership unites two leading genomic interpretation platforms to provide advanced, literature-backed insights that strengthen decision-making processes in […]
Plexitome™ and VEO Ophthalmics Medical Partner to Transform Corneal Surgery
Plexitome™, an innovative device designed for anterior stromal puncture (ASP), is now being introduced through a strategic collaboration between Plexitome Medical and VEO Ophthalmics, a recognized leader in advanced ophthalmic technologies. This breakthrough tool is engineered to deliver unmatched accuracy and consistency, positioning it as a transformative solution for treating […]
Phraxis Completes First Commercial EndoForce™ Procedure in the U.S.
A significant milestone in the treatment of dialysis patients worldwide has been reached with the successful completion of the first commercial procedure utilizing Phraxis, Inc., a leader in vascular access innovation. The landmark treatment was carried out at Spartanburg Regional Medical Center in Spartanburg, South Carolina, by vascular access surgeon […]
SmartLabs and Sonrai Unite to Deliver Exclusive AI Solutions for Biotech Innovation
SmartLabs and Sonrai Analytics have announced a global strategic partnership to bring Sonrai’s next-generation AI capabilities into SmartLabs’ network of advanced research centers. Sonrai’s AI-powered analytics platform, Sonrai Discovery, will be made available to its member companies by SmartLabs as a result of this partnership. Additionally, solely within the SmartLabs […]
Fujitsu Unveils Healthcare AI Platform to Accelerate Operational Transformation
In order to improve operational efficiency and fortify the stability of medical service delivery in Japan’s healthcare sector, Fujitsu has revealed the creation of a safe and incredibly effective AI agent platform. At the core of this new platform is an orchestrator AI agent, a centralized system that enables the […]
Quest Diagnostics’ Haystack MRD® Test Earns FDA Breakthrough Device Designation for Early-Stage Colorectal Cancer
Quest Diagnostics (NYSE: DGX), a prominent leader in diagnostic information services, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Haystack MRD® test. This innovative test is designed to identify MRD-positive patients with stage II colorectal cancer following curative-intent surgery, helping determine which […]
